Trends in European Disposable E-cigarette Market's New Flavors

Apr.27.2023
Trends in European Disposable E-cigarette Market's New Flavors
2FIRSTS analyzes European e-cigarette market trends through multiple perspectives, revealing new flavor trends and growth in disposable e-cigarettes.

Recently, 2FIRSTS conducted a comprehensive analysis of the European e-cigarette market, focusing on dimensions such as flavor, company, brand, e-liquid, and appearance. This analysis was based on official information from important logistics centers in Europe. By utilizing multiple perspectives, 2FIRSTS was able to gain insight into the future trends of the European e-cigarette market.


Official data released shows that in March, there were 319 new electronic cigarette products introduced in Europe. Disposable e-cigarettes accounted for over 85% of these new products, while pod-based e-liquids and cartridge-based e-liquid kits made up 9.6% and 7.2%, respectively.


2FIRSTS has conducted an in-depth analysis of the European disposable e-cigarette market's new flavor trends from a flavor standpoint, based on this "incremental data." The data shows that the most prominent growth occurred in grape ice, watermelon ice, strawberry ice, and mango peach flavors. Mixed fruit flavors also saw an increase, including strawberry banana, strawberry, blueberry, and cherry blends, as well as kiwi passion fruit guava. Mixed berries had the largest increase, growing 10.7% year-over-year.


It is expected that by October 2023, the aforementioned flavors will become the new flavors with the highest increase in market volume in the European Bai Guan market.


Image: Distribution of mixed flavors of new electronic cigarette products in April | Data source: European Health Department whitelist, 2FIRSTS Note: The above chart only counts the number of times various flavor keywords appear simultaneously. If it is a mixed flavor of three flavors, it will be counted once in each of the two flavors.


Furthermore, there has been a significant increase in flavors such as pineapple, banana, guava, peach, mango, and grape, all with growth rates exceeding 8%. (Note: This increase refers to all flavors containing the respective fruit, including mixed fruit flavors.)


Incremental Contribution Ratio | Image source: 2FIRSTS exclusive compilation. The chart is derived from the free website http://www.flaticon.com.


2FIRSTS will continue to report on research and analysis of the European e-cigarette market. Stay tuned for updates.


The data and images in this article were compiled by 2FIRSTS based on the e-cigarette whitelist published by Belgium. Belgium is an important logistics hub in Europe, with Brussels Airport being a key port for Chinese e-cigarettes to set sail. Additionally, Belgium has established a free trade zone called Benelux with the Netherlands and Luxembourg, allowing for free flow of goods within the trade zone. Belgium requires all imported and manufactured products to be registered and recorded on their "whitelist" six months before being placed on the market. This whitelist is published by the Federal Public Service of Health, Environment and Food Chain Safety in Belgium (FPS Public Health).


Further reading:


According to a market research by 2FIRSTS, narrowing of electronic cigarette flavors is an inevitable trend as the market moves towards further segmentation.


2FIRSTS Market Research: Only Accepting White Labels and Forced Transformation - How is the Russian E-Cigarette Market Doing Under Strong Regulatory Signals?


What impact has the "e-liquid exceeding standards" incident had on the electronic cigarette distributors in Manchester, UK?


2FIRSTS recently interviewed the electronic cigarette brand Fume, which claims to be the first in Florida. The company is currently developing a new hybrid flavor.


A survey conducted by 2FIRSTS on the appearance of electronic cigarettes in Europe found that black, blue, and red are the most popular colors, while green and pink are experiencing the fastest growth.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
South Korean tobacco company KT&G launched the limited-edition lil HYBRID 3.0 Misty Rosé Edition II on September 30, 2026, following the original Misty Rosé Edition introduced in November 2025. The new release comes in two pink finishes, Bloom Rosé and Viva Rosé, each priced at 88,000 won. Both versions initially went on sale through the lil Store online shop and lil MINIMALIUM flagship stores. From October 7, Bloom Rosé became available at approximately 1,500 lil Station retail outlets nationwide. The release retains the existing lil HYBRID 3.0 hybrid heated tobacco platform, with changes focused on exterior design and distribution.
product
Oct.10
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
The White House withdrew Heidi Overton's nomination to lead the U.S. Food and Drug Administration (FDA) on November 17, 2026, a day before a scheduled Senate committee vote. Overton faced questions from Republican and Democratic senators over vaccines, abortion medication and flavored nicotine products. In May, the FDA granted its first marketing authorizations for non-tobacco, non-menthol e-cigarette flavors, including mango and blueberry pods from Glas. Republican Senator Susan Collins challenged recent authorizations for flavored vaping and nicotine pouch products during Overton's September confirmation hearing. The FDA remains under Acting Commissioner Kyle Diamantas.
FDA
Nov.18
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How are investors reassessing the global tobacco industry as nicotine markets evolve? In an interview with 2Firsts, Charlie Chen, Head of Research at CCB International Securities, forecasts annual growth of 30–50% for nicotine pouches, outpacing vaping and heated tobacco. He examines how regulatory enforcement, shifting market shares and new business models are influencing company valuations. The report also explores differences between multinational tobacco groups and Chinese companies, drawing on insights from the New Approaches Summit on profitability, investment strategies and industry consolidation.
Nov.11